Skip to main content
. 2020 Jan 22;5(4):1773–1781. doi: 10.1021/acsomega.9b02263

Figure 2.

Figure 2

Schematic representation for the identification of potential compounds. (A) Virtual screening process. (B) Binding affinity assessment. (C) Knowledge-based screening. (D) Compounds demonstrating the pharmacophore features.